Ultra Supplement LLC recalls SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor

Recalled August 10, 2022 · FDA recall D-1350-2022 · Ultra Supplement

Hazard

Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil. · FDA Class I

Units

750 cartons

Sold at

Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.

Description

Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.

Product

SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.

Manufacturer(s)

Ultra Supplement LLC

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →